此页面是自动翻译的,不保证翻译的准确性。请参阅 英文版 对于源文本。

Adaptation of Facilitated Access to Mutual Aid for Community Alcohol and Drug Services (FAMA)

2026年11月16日 更新者:King's College London

Adaptation of a Facilitated Access to Mutual Aid (FAMA) Intervention for Adults Accessing Community Alcohol and Drug Services in England.

Alcohol and other drug (AOD) use disorders are associated with a range of adverse outcomes. Relapse following AOD treatment is common. Attendance at Mutual Aid Groups (MAGs) is associated with improved health outcomes and reduced healthcare utilisation costs. National guidance recommends that clinical staff promote MAG attendance, but few patients are referred to, or attend, MAGs. An intensive referral intervention, developed in the United States of America has been shown to increase engagement with MAGs. The aim of this National Institute for Health Research (NIHR)-funded study is to adapt and test a Facilitated Access to Mutual Aid (FAMA) intervention and staff training for delivery in community AOD services in England.

Phase one of this study consists of qualitative focus groups conducted with staff of community AOD services and adults receiving AOD treatment. Eight focus groups will explore participants' views of MAGs and the existing American FAMA intervention. The FAMA intervention will then be adapted and staff training developed, based on the focus group findings and input from patient and public involvement and engagement (PPIE) groups.

Phase two of this study consists of testing the adapted FAMA intervention. Staff in one community AOD service will receive the newly developed FAMA training. They will deliver FAMA to people who are currently receiving AOD treatment service. Each session will be recorded and the fidelity of intervention delivery will be assessed by the research team using a checklist. Staff and patient feedback will be collected using brief questionnaires in informal feedback sessions. The FAMA intervention will be refined and delivered again with another round of feedback being collected. A final version of the FAMA intervention will then be agreed by the research team and PPIE groups.

研究概览

地位

尚未招聘

条件

研究类型

观察性的

注册 (估计的)

84

参与标准

研究人员寻找符合特定描述的人,称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。

资格标准

适合学习的年龄

18年 及以上 (成人、年长者)

接受健康志愿者

不

有资格学习的性别

全部

取样方法

非概率样本

研究人群

Adults aged 18+ years who are accessing AOD treatment and staff, aged 18+ years who are working in paid client facing role in an AOD treatment service.

描述

Phase one (staff) inclusion criteria:

  • Aged 18+ years
  • Currently working in a paid client facing role in an AOD treatment service

Phase one (people accessing AOD treatment) inclusion criteria:

  • Aged 18+ years
  • Currently receiving treatment from an AOD treatment service

Phase two (staff) inclusion criteria:

  • Aged 18+ years
  • Currently working as a keyworker or recover worker in an AOD treatment service

Phase two (people accessing AOD treatment) inclusion criteria:

  • Aged 18+ years
  • Currently receiving treatment from an AOD treatment service
  • On a participating staff member's caseload
  • Not attending MAGs.

Exclusion Criteria:

  • N/A

学习计划

本节提供研究计划的详细信息,包括研究的设计方式和研究的衡量标准。

研究是如何设计的?

设计细节

  • 观测模型:OTHER
  • 时间观点:CROSS_SECTIONAL

研究衡量的是什么?

主要结果指标

结果测量
措施说明
大体时间
Qualitative focus groups
大体时间:Focus groups will last approximately 90 minutes

Qualitative focus groups

Focus groups will last approximately 90 minutes
Acceptability of Intervention measure (AIM) adapted for FAMA
大体时间:Maximum 10 weeks from enrolment in the study

Measures whether participants find FAMA to be acceptable

Maximum 10 weeks from enrolment in the study
Feasibility of Intervention (FIM) adapted for FAMA
大体时间:Maximum 10 weeks from enrolment in the study

Measures whether participants find FAMA to be feasible

Maximum 10 weeks from enrolment in the study
Appropriateness Measure (IAM) adapted for FAMA
大体时间:Maximum 10 weeks from enrolment in the study

Measures whether participants find FAMA to be appropriate

Maximum 10 weeks from enrolment in the study

合作者和调查者

在这里您可以找到参与这项研究的人员和组织。

研究记录日期

这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查,以确保它们在发布到公共网站之前符合特定的质量控制标准。

研究主要日期

学习开始 (估计的)

2026年11月20日

初级完成 (估计的)

2026年12月31日

研究完成 (估计的)

2026年12月31日

研究注册日期

首次提交

2026年11月10日

首先提交符合 QC 标准的

2026年11月16日

首次发布 (实际的)

2026年11月18日

研究记录更新

最后更新发布 (实际的)

2026年11月18日

上次提交的符合 QC 标准的更新

2026年11月16日

最后验证

2026年11月1日

更多信息

与本研究相关的术语

其他相关的 MeSH 术语

其他研究编号

  • IRAS 370125

药物和器械信息、研究文件

研究美国 FDA 监管的药品

不

研究美国 FDA 监管的设备产品

不

此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.

订阅